Inge G P Geelen - Department of Hematology, Albert Schweitzer Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Switching from Imatinib to Nilotinib Plus Pegylated Interferon-Α2b in Chronic Phase CML Failing to Achieve Deep Molecular Response: Clinical and Immunological Effects

Inge G.P. Geelen,Stein-Erik Gullaksen,Mette M. Ilander,Ulla Olssen-Strömberg,Satu Mustjoki,Johan Richter,Nicole M.A. Blijlevens,Willem M. Smit,Bjorn T. Gjertsen,Tobias Gedde-Dahl,Berit Markevärn, Malika M.A. Koppes,Peter E. Westerweel,Henrik Hjorth-Hansen,Jeroen J.W.M. Janssen

Annals of Hematology（2023）

引用1浏览0WOS引用

Adherence to Quality Indicators in Chronic Myeloid Leukemia Care: Results from a Population-Based Study in the Netherlands

Genevieve I. C. G. Ector,Inge G. P. Geelen,Avinash G. Dinmohamed,Mels Hoogendoorn,Peter E. Westerweel,Rosella P. M. G. Hermens,Nicole M. A. Blijlevens

LEUKEMIA & LYMPHOMA（2023）

引用1浏览0WOS引用

BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population

Camille Kockerols,Peter J. M. Valk,Nicole M. A. Blijlevens,Jan J. Cornelissen,Avinash G. Dinmohamed,Inge Geelen,Mels Hoogendoorn,Jeroen J. W. M. Janssen,Laura G. M. Daenen,Bert A. van der Reijden,Peter E. Westerweel

Blood（2023）

引用0浏览0WOS引用

High-risk Additional Cytogenetic Aberrations in a Dutch Chronic Phase Chronic Myeloid Leukemia Patient Population

Camille C B Kockerols,Inge G P Geelen,Mark-David Levin,Jeroen J W M Janssen, H Berna Beveloo,Avinash G Dinmohamed,Mels Hoogendoorn,Jan J Cornelissen,Peter E Westerweel

Haematologica（2023）

引用0浏览0WOS引用

The Use of Hydroxyurea Pretreatment in Chronic Myeloid Leukemia in the Current Tyrosine Kinase Inhibitor Era

Camille C. B. Kockerols,Inge Geelen,Mark-David Levin,Jeroen J. W. M. Janssen,Avinash G. Dinmohamed,Mels Hoogendoorn,Jan J. Cornelissen,Peter E. Westerweel

Haematologica（2022）

引用4浏览0WOS引用

Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukemia: Patient Views

Vashti N. M. F. Tromp,Lonneke Timmers,Leanne Koningen,Jeroen J. W. M. Janssen,Peter E. Westerweel,Inge G. P. Geelen,Jan de Jong, Jan J. Beckeringh,Christel C. L. M. Boons,Jacqueline G. Hugtenburg

Leukemia & lymphoma/Leukemia and lymphomano. 3 (2020): 649-658

引用3浏览0WOS引用

Blood Cell Counts and Lymphocyte Subsets of Patients Admitted During the COVID‐19 Pandemic: a Prospective Cohort Study

Paul J. Hengeveld, Aaram O. Khader, Linda H. A. de Bruin,Inge G. P. Geelen,Eske A. van Baalen, Eva Jansen,Nathalie I. Bouwer, Omer Balak,Jurgen A. Riedl,Anton W. Langerak,Peter E. Westerweel,Mark-David Levin

BRITISH JOURNAL OF HAEMATOLOGYno. 4 (2020): E201-E204

引用0浏览0引用

Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study

BRITISH JOURNAL OF HAEMATOLOGY（2020）

引用13浏览0WOS引用

Prestop: Patients perspective on discontinuation of CML TKI-treatment

Vashti N. M. F. Tromp,Lonneke Timmers,Leanne Koningen,Jeroen J. W. M. Janssen,Peter E. Westerweel,Inge G. P. Geelen,Jan de Jong,Christel C. L. M. Boons,Jacqueline G. Hugtenburg

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2019）

引用23浏览0引用

Validation of the EUTOS Long-Term Survival Score in a Recent Independent Cohort of “real World” CML Patients

Inge G. P. Geelen,Fredrik Sandin,Noortje Thielen,Jeroen J. W. M. Janssen,Mels Hoogendoorn,Otto Visser,Jan J. Cornelissen,Martin Hoglund,Peter E. Westerweel

Leukemia（2018）

引用29浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn